Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 53 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

23%

12 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

15 recruiting

Enrollment Performance

Analytics

N/A
14(40.0%)
Phase 4
9(25.7%)
Phase 2
6(17.1%)
Phase 3
3(8.6%)
Phase 1
2(5.7%)
Early Phase 1
1(2.9%)
35Total
N/A(14)
Phase 4(9)
Phase 2(6)
Phase 3(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (53)

Showing 20 of 53 trials
NCT06204094Phase 2Recruiting

Node-sparing Radiotherapy Combined With Total Neoadjuvant CAPOX and Sintilimab for MSS Middle and Low Rectal Cancer

Role: lead

NCT07507825Phase 2Not Yet Recruiting

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Role: collaborator

NCT06792786Not ApplicableRecruiting

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Role: collaborator

NCT07480785Not ApplicableRecruiting

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients

Role: collaborator

NCT06807372Active Not Recruiting

Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy

Role: collaborator

NCT06484374Not ApplicableRecruiting

A Multicenter, RAndomlzed, coNtrolled, umBrella Trial fOr Minimally Invasive Neurosurgery With Al-assisted Robotic guidanCe for Hemorrhagic Stroke: Large Basal Ganglia Hemorrhage

Role: collaborator

NCT07413809Phase 3Recruiting

Prevention of Delayed CINV After Autologous Transplant: Olanzapine-Containing Regimen vs. Dexamethasone-Containing Regimen

Role: collaborator

NCT06769685Enrolling By Invitation

TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II

Role: lead

NCT07266168Not ApplicableNot Yet Recruiting

Efficacy and Safety of Ivarmacitinib in the Treatment of Patients With Polymyalgia Rheumatica

Role: collaborator

NCT07088757Phase 4Recruiting

Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis

Role: collaborator

NCT03957707Not ApplicableActive Not Recruiting

Sterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT07114120Phase 4Recruiting

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules

Role: collaborator

NCT04961515Phase 2Recruiting

Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma

Role: collaborator

NCT04624295Phase 4Recruiting

Early Antiplatelet Therapy After Hemorrhagic Infarction in Acute Ischemic Stroke Treated With Intravenous Thrombolysis (HITs)

Role: collaborator

NCT06946732Not ApplicableRecruiting

Acostream Use in Patients With High Risk and Intermediate-risk Acute Pulmonary Embolism

Role: collaborator

NCT06218485Not ApplicableRecruiting

FFR Versus IVUS with Angiography-Derived FFR for Clinical Outcomes in Patients with Coronary Artery Disease

Role: collaborator

NCT06721988Not ApplicableNot Yet Recruiting

Effect of Preventive Analgesia with Oxycodone and Parecoxib Sodium on the Chronification of Acute Post-operative Pain

Role: collaborator

NCT06713655Not Yet Recruiting

Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation

Role: collaborator

NCT06709144Phase 3Active Not Recruiting

Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer

Role: collaborator